SIM
ALPN icon

Spark Investment Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Spark Investment Management’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-13,600
Closed -$108K – 750
2018
Q1 		$108K Sell
13,600
-3,000
-18% -$29.6K 0.01% 546
2017
Q4 		$185K Sell
16,600
-13,900
-46% -$151K 0.01% 583
2017
Q3 		$353K Sell
30,500
-1,700
-5% -$15.9K 0.02% 531
2017
Q2 		$310K Sell
32,200
-9,945
-24% -$95.3K 0.02% 574
2017
Q1 		$492K Buy
42,145
+35,945
+580% +$364K 0.03% 538
2016
Q4 		$55K Buy
6,200
+1,725
+39% +$34.4K ﹤0.01% 739
2016
Q3 		$145K Buy
+4,475
New +$109K 0.01% 711
2016
Q1 		– Sell
-10,750
Closed -$332K – 854
2015
Q4 		$332K Buy
10,750
+5,250
+95% +$179K 0.04% 448
2015
Q3 		$286K Buy
+5,500
New +$361K 0.04% 471

Other funds holding ALPN

OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
Deerfield Management
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BVF Inc
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Bridgeway Capital Management
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Spark Investment Management's ALPN Position: Q2 2018 in Review

Spark Investment Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2018, closing a stake of 13,600 shares — an estimated $108K sold.

Spark Investment Management first reported a position in ALPN in Q3 2015 and held it in 9 quarters. The position peaked at $492K in Q1 2017. 24 funds tracked by Wall St. Rank hold ALPN as of Q2 2018.

  • Spark Investment Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2018 after selling out during the quarter.
  • Spark Investment Management sold 13,600 Alpine Immune Sciences Inc shares in Q2 2018, an estimated $108K.
  • Spark Investment Management first reported a position in Alpine Immune Sciences Inc in Q3 2015 and held it in 9 quarters.
  • Spark Investment Management's Alpine Immune Sciences Inc position peaked at $492K in Q1 2017.
  • 24 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2018.

Based on Spark Investment Management's 13F filing for Q2 2018, filed 8 Aug 2018.